Login / Signup

Myocarditis associated with COVID-19 vaccination.

Alessandra BuoninfanteArno C AndewegGeorgy GenovMarco Cavaleri
Published in: NPJ vaccines (2024)
Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory authorities worldwide. COVID-19 vaccines have been administered to several million people and the risk of myocarditis post COVID-19 vaccination has been characterised in great detail. At the present time the research data available are scarce and there is still no clear understanding of the biological mechanism/s responsible for this disease. This manuscript provides a concise overview of the epidemiology of myocarditis and the most prominent mechanistic insights in the pathophysiology of the disease. Most importantly it underscores the needed next steps in the research agenda required to characterize the pathophysiology of this disease post-COVID-19 vaccination. Finally, it shares our perspectives and considerations for public health.
Keyphrases
  • coronavirus disease
  • sars cov
  • public health
  • respiratory syndrome coronavirus
  • transcription factor
  • risk factors
  • big data
  • binding protein